European stocks head for positive open but concerns over inflation dominate market sentiment

European stocks head for positive open but concerns over inflation dominate market sentiment


China’s consumer inflation slows further in December, stoking deflation worries

China’s consumer price inflation in December slipped to 0.1% year on year, data from the National Bureau of Statistics showed Thursday, stoking deflation concerns.

Growth in headline inflation was in line with Reuters estimates, but less than the 0.2% rise in November. Core CPI, which excludes food and energy prices, rose 0.4% year on year compared with 0.3% rise in the previous month, the data showed.

On a month-on-month basis, China’s CPI came in flat, compared with the 0.6% decline in the prior month.

Food prices fell by 0.6% month on month as a result of conducive weather conditions, official statistics showed. The prices of fresh vegetables and fruits fell 2.4% and 1%, respectively. Prices of pork, which makes up a significant portion of the CPI basket, fell 2.1%.

— Lee Ying Shan

CNBC Pro: Beyond Tencent: Goldman refreshes its list of top Asian stocks — giving one nearly 50% upside

Goldman Sachs is cautious on Chinese tech behemoth Tencent Holdings, removing it from its Asia-Pacific “conviction list” of top picks.

The investment bank also removed several other stocks from the list and added others, including one it gives nearly 50% upside.

CNBC Pro subscribers can read more here.

— Amala Balakrishner

CNBC Pro: Bernstein says Taiwanese chip supplier to benefit in 2026

MediaTek, the Taiwanese semiconductor company collaborating with Nvidia on its newly announced small AI supercomputer, is expected to see significant financial benefits from the partnership starting in 2026, according to Bernstein.

Nvidia’s desktop supercomputer, priced starting at $3,000, is set to launch in May 2025.

CNBC Pro subscribers can read more here.

— Ganesh Rao

Fed minutes show officials worried about inflation impact from Trump policies

A summary of the Fed’s December meeting showed central bank officials were concerned about how policies from the incoming Trump administration could impact inflation.

“Almost all participants judged that upside risks to the inflation outlook had increased,” the minutes said. “In discussing the outlook for monetary policy, participants indicated that the Committee was at or near the point at which it would be appropriate to slow the pace of policy easing.”

— Fred Imbert

European markets: Here are the opening calls

European markets are expected to open in positive territory Thursday.

The U.K.’s FTSE 100 index is expected to open 13 points higher at 8,256, Germany’s DAX up 44 points at 20,361, France’s CAC up 8 points at 7,454 and Italy’s FTSE MIB up 2 points at 35,210, according to data from IG.

Earnings releases include trading statements from M&S, Tesco and Greggs. German trade balance data for November is due to be released Thursday.

— Holly Ellyatt



Source

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World
World

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email On today’s episode of CNBC Crypto World, bitcoin falls as Wall Street rethinks some AI investments. Also, CF Benchmarks CEO Sui Chung discusses recent trends in crypto ETFs. Source

Read More
The chart that has Michael Burry worried about the stock market
World

The chart that has Michael Burry worried about the stock market

Michael Burry is warning that a shift in household wealth could leave the stock market vulnerable to a long and significant downturn. “The Big Short” investor pointed to a graphic produced by Wells Fargo showing that U.S. households now hold a larger share of their net worth in equities than in real estate — a […]

Read More
This biotech name is evolving into a major obesity play. How to trade it with options
World

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline due to Medicare pricing reform, management has demonstrated credible execution in replacing that cash flow with a higher-quality pipeline. Early success from the Imdelltra […]

Read More